Results 211 to 220 of about 47,512 (271)

Impacts of Mitochondrial Status After Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma Patients

open access: yesCancer Science, Volume 117, Issue 2, Page 491-500, February 2026.
We described the prognostic impacts of mitochondrial status after neoadjuvant chemotherapy and its association with the tumor microenvironment in esophageal squamous cell carcinoma patients. High Mito‐score after NAC identifies ESCC patients with significantly poorer survival, particularly among those with advanced pathological stages, thereby possibly
Kotaro Sugawara   +8 more
wiley   +1 more source

Rectal cancer following radiotherapy for prostate cancer: A propensity‐matched analysis

open access: yesColorectal Disease, Volume 28, Issue 2, February 2026.
Abstract Aim Patients who have previously received radiation therapy for primary prostate cancer (PPC) face an elevated risk of developing secondary rectal cancer (SRC). However, the clinical presentation, surgical outcomes, and oncological results of SRC in this context remain poorly characterized.
M. Goldenshluger   +10 more
wiley   +1 more source

The significance of MRI‐detected lateral lymph node metastasis in rectal cancer on local recurrence and survival—A nationwide cohort study

open access: yesColorectal Disease, Volume 28, Issue 2, February 2026.
Abstract Aim This retrospective observational cohort study aimed to investigate the prevalence of suspected lateral lymph node metastases (LLNM), as diagnosed by magnetic resonance imaging (MRI), and its impact on local recurrence (LR) and overall survival (OS).
Erik Agger   +3 more
wiley   +1 more source

CDKN2A deletion in p16‐negative/HPV‐positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement

open access: yesHistopathology, Volume 88, Issue 3, Page 664-672, February 2026.
We present a case series of HPV‐positive non‐keratinizing squamous cell carcinoma of the head and neck with discordant negative p16 staining due to CDKN2A deletion. These findings highlight the genomic basis behind the diagnostic pitfall of reliance on p16 immunohistochemistry as a surrogate marker of HPV and raise practice‐changing considerations for ...
Trevor Teich   +8 more
wiley   +1 more source

Pathologic assessment of resected stage III non‐small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors

open access: yesHistopathology, Volume 88, Issue 3, Page 710-728, February 2026.
Multiple pathological variables are associated with prognosis in resected NSCLC at stage III undergoing neoadjuvant treatment, namely vascular, perineural and pleural infiltration, proliferation index, pathological response, fibrosis and presence of lymphocytes in the tumour bed.
Francesca Lunardi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy